A retrospective study assessing the prognostic value of blasts in peripheral blood in Myelofibrosis patients treated with Ruxolitinib
Latest Information Update: 28 Jul 2020
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Pharmacodynamics; Therapeutic Use
- 28 Jul 2020 New trial record
- 22 Jul 2020 Results published in the Cancer